DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-285 Cr | ₹50 Cr | ₹193 Cr | ₹-1,045 Cr | ₹-816 Cr |
What is the latest Net Cash Inflow / Outflow ratio of DIVIS LABORATORIES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-285 Cr |
| Mar2025 | ₹50 Cr |
| Mar2024 | ₹193 Cr |
| Mar2023 | ₹-1,045 Cr |
| Mar2022 | ₹-816 Cr |
How is Net Cash Inflow / Outflow of DIVIS LABORATORIES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-285 Cr | Negative | |
| Mar2025 | ₹50 Cr | -74.09 | |
| Mar2024 | ₹193 Cr | Positive | |
| Mar2023 | ₹-1,045 Cr | Negative | |
| Mar2022 | ₹-816 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹264,172.5 Cr | 5% | 7.2% | 49.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,202.0 Cr | 0.5% | -2.9% | 5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,402.0 Cr | -0.5% | -4.5% | 28.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,868.0 Cr | 2.7% | 8.4% | 5.1% | Stock Analytics | |
| CIPLA | ₹111,650.0 Cr | 2.4% | 2.4% | -12.9% | Stock Analytics | |
| MANKIND PHARMA | ₹102,196.0 Cr | -1.1% | -1.2% | 3.1% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 5% |
7.2% |
49.7% |
| SENSEX | 2.8% |
4.4% |
-10.1% |
You may also like the below Video Courses